Page last updated: 2024-10-20

pyridoxine and Carcinoma, Papillary

pyridoxine has been researched along with Carcinoma, Papillary in 1 studies

4,5-bis(hydroxymethyl)-2-methylpyridin-3-ol: structure in first source
vitamin B6 : Any member of the group of pyridines that exhibit biological activity against vitamin B6 deficiency. Vitamin B6 deficiency is associated with microcytic anemia, electroencephalographic abnormalities, dermatitis with cheilosis (scaling on the lips and cracks at the corners of the mouth) and glossitis (swollen tongue), depression and confusion, and weakened immune function. Vitamin B6 consists of the vitamers pyridoxine, pyridoxal, and pyridoxamine and their respective 5'-phosphate esters (and includes their corresponding ionized and salt forms).

Carcinoma, Papillary: A malignant neoplasm characterized by the formation of numerous, irregular, finger-like projections of fibrous stroma that is covered with a surface layer of neoplastic epithelial cells. (Stedman, 25th ed)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pavone-Macaluso, M1
Tripi, M1
Ingargiola, GB1

Trials

1 trial available for pyridoxine and Carcinoma, Papillary

ArticleYear
Cooperative studies of chemoprophylaxis after transurethral resection of bladder tumors.
    Cancer chemotherapy and pharmacology, 1983, Volume: 11 Suppl

    Topics: Antineoplastic Agents; Carcinoma, Papillary; Cisplatin; Clinical Trials as Topic; Combined Modality

1983